Literature DB >> 23140485

Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function.

Matteo Anselmino1, Stefano Grossi, Marco Scaglione, Davide Castagno, Francesca Bianchi, Gaetano Senatore, Mario Matta, Dario Casolati, Federico Ferraris, Yvonne Cristoforetti, Alessandro Negro, Fiorenzo Gaita.   

Abstract

INTRODUCTION: Long-term outcome of AF ablation in patients with impaired LVEF is unknown. The aim of this study is to evaluate sinus rhythm (SR) maintenance, clinical status, and echocardiographic parameters over a long-term period following atrial fibrillation (AF) transcatheter ablation in patients with left ventricular ejection fraction (LVEF) <50%. METHODS AND
RESULTS: A total of 196 patients (87.2% males, age 60.5 ± 10.2 years) with LVEF <50% underwent radiofrequency transcatheter ablation for paroxysmal (22.4%) or persistent (77.6%) AF. Patients were followed up for 46.2 (16.4-63.5) months regarding AF recurrences, functional class, and echocardiographic parameters. All patients underwent pulmonary vein isolation, while 167 (85.2%) required additional atrial lesions. Eleven (5.6%) patients suffered procedural complications. During follow-up, 58 (29.6%) patients required repeated ablations. At the follow-up end, 15 (7.7%) patients died, while 74 (37.8%) documented at least one episode of AF, atrial flutter, or atrial ectopic tachycardia. Eighty-three (47.2%) patients maintained antiarrhythmic drugs. During follow-up, NYHA class improved by at least one class more frequently among patients maintaining SR compared to those experiencing relapses (70.6% vs 47.9%, P = 0.003). LVEF showed a broader relative increase in patients maintaining SR (32.7% vs 21.4%; P = 0.047) and mitral regurgitation grading significantly decreased (P <0.001) only within these patients. At multivariable analysis SR maintenance emerged as an independent predictor (odds ratio 4.26, 95% CI 1.69-10.74, P = 0.002) of long-term clinical improvement (reduction in NYHA class ≥ 1 and relative increase in LVEF ≥ 10%).
CONCLUSIONS: Although not substantially worse than in patients with preserved LVEF, AF ablation in patients with impaired LVEF is affected by high long-term recurrence rate. Among these patients SR maintenance is associated with greater clinical improvement.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23140485     DOI: 10.1111/j.1540-8167.2012.02419.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  15 in total

1.  Catheter ablation of atrial fibrillation in patients with severely impaired left ventricular systolic function.

Authors:  Ken Kato; Koichiro Ejima; Noritoshi Fukushima; Makoto Ishizawa; Osamu Wakisaka; Ryuta Henmi; Kentaro Yoshida; Toshiaki Nuki; Kotaro Arai; Bun Yashiro; Tetsuyuki Manaka; Kyomi Ashihara; Morio Shoda; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2015-01-30       Impact factor: 2.037

Review 2.  Catheter ablation in atrial fibrillation: is there a mortality benefit in patients with diabetes and heart failure?

Authors:  M Matta; A Saglietto; P De Salvo; A Bissolino; A Ballatore; M Anselmino
Journal:  Herz       Date:  2019-05       Impact factor: 1.443

Review 3.  Cardiac Remodeling After Atrial Fibrillation Ablation.

Authors:  Li-Wei Lo; Shih-Ann Chen
Journal:  J Atr Fibrillation       Date:  2013-06-30

4.  Acute effects of adrenergic agents on post-defibrillation arrest time in a cultured heart model.

Authors:  V Krauthamer; T C Smith
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

Review 5.  Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials.

Authors:  Chen Chen; Xinbin Zhou; Min Zhu; Shenjie Chen; Jie Chen; Hongwen Cai; Jin Dai; Xiaoming Xu; Wei Mao
Journal:  J Interv Card Electrophysiol       Date:  2018-03-16       Impact factor: 1.900

Review 6.  Comorbidity of atrial fibrillation and heart failure.

Authors:  Liang-Han Ling; Peter M Kistler; Jonathan M Kalman; Richard J Schilling; Ross J Hunter
Journal:  Nat Rev Cardiol       Date:  2015-12-10       Impact factor: 32.419

Review 7.  Effects of radiofrequency catheter ablation on left ventricular structure and function in patients with atrial fibrillation: a meta-analysis.

Authors:  Pengju Zhu; Yong Zhang; Peiqing Jiang; Zhongsu Wang; Jiangrong Wang; Xiangcui Yin; Yinglong Hou
Journal:  J Interv Card Electrophysiol       Date:  2014-06-26       Impact factor: 1.900

Review 8.  Efficacy and safety of catheter ablation vs. rate control of atrial fibrillation in systolic left ventricular dysfunction : A meta-analysis and systematic review.

Authors:  B Zhang; D Shen; S Feng; Y Zhen; G Zhang
Journal:  Herz       Date:  2015-11-23       Impact factor: 1.443

Review 9.  Ablation for Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction.

Authors:  Jackson J Liang; David J Callans
Journal:  Card Fail Rev       Date:  2018-05

10.  Atrial Fibrillation in Heart Failure Patients with Preserved or Reduced Ejection Fraction. Prognostic significance of Rhythm control strategy with Catheter Ablation.

Authors:  Nicolás Vecchio; Leonardo Ripa; Agustín Orosco; Leandro Tomas; Ignacio Mondragón; Adriana Acosta; Lujan Talavera; Santiago Rivera; Gastón Albina; Mirta Diez; Fernando Scazzuso
Journal:  J Atr Fibrillation       Date:  2019-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.